While indemnification claims, purchase price adjustments, earn-out achievement disputes and other post-closing issues in private-target M&A transactions remain common, data shows that claim resolution is becoming more efficient.
SRS | Shareholder Representative Services announced the release of the 2013 SRS M&A Post-Closing Claims Study, which analyzes post-closing issues and payouts across 420 private-target acquisitions, comprising $66.7 billion in stated deal value with $6.7 billion held in escrow and $9 billion in potential earn-out consideration.
The study presents aggregate data from nearly 700 claims, including new data points on specific claim types, claim and escrow payouts, and earn-out milestone achievement rates. Overall, the study shows that two thirds of all deals had issues arise after closing, and one in five deals with claims had exposure exceeding half of the escrow. Additionally, earn-out milestones for technology and other deals outside of the life sciences sector were achieved 50% of the time.
“Parties should focus on the issues that are likely to impact returns and the timing of payouts after closing,” said Paul Koenig, co-CEO and managing director of SRS. “Better access to information is helping buyers and sellers resolve post-closing issues more effectively or avoid them altogether.”
Additional key findings from the study include:
“The SRS Claims Study is instructive for deal makers seeking to mitigate potential post-closing exposures as they negotiate transactions and finalize deal documents,” said Chris Letang, managing director and head of SRS’ post-closing claims team. “While it is difficult to avoid all disputes, our data shows that the claims resolution process has become much more efficient, allowing buyers to collect on agreed losses and shareholders to realize final merger consideration on a more timely basis.”
The full 2013 SRS M&A Post-Closing Claims Study is available on the SRS web site.
SRS | Shareholder Representative Services manages post-closing processes to safeguard the selling shareholders’ interests in private company M&A transactions.